Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

Clinical trial NCT00081783 · UNKNOWN

Trial details

NCT number: NCT00081783
Sponsor: Xcyte Therapies
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2004-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.